Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events

Released On
April 13, 2020

Expires On
April 13, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Hematology-Oncology

Topic(s)
Oncology

Scroll to the Bottom of this Information to Begin this Course

Provided by Med Learning Group.

Co-provided by Ultimate Medical Academy/CCM and AMEDCO.

 

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 ANCC Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses, and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Program Overview

This whiteboard preceptorship will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Learning Objectives

Upon completion of the program, attendees should be able to:

  • Review potential predictive or prognostic immune-related biomarkers and biomarker testing methodologies
  • Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents.
  • Recognize and manage immune-related adverse events (irAEs) associated with the use of checkpoint inhibitors
  • Explain patient-centered shared decision-making approaches aimed at optimizing cancer care and survivorship and the roles of the multidisciplinary team members in diagnosing and managing irAEs.

Faculty

Arjun V. Balar, MD

Assistant Professor of Medicine
Director, Genitourinary Medical Oncology Program
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, NY

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation Statement

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information

Purpose: This program would be beneficial for nurses involved in the care of patients who are treated or eligible for treatment with immunotherapy. Credits: 1.0 ANCC Contact Hour.

ONCC Statement

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Successful completion of this program qualifies for up to 1.0 knowledge-based credit hour.

Event UAN(s): JA4008163-9999-20-048-H04-P, JA4008163-9999-20-048-H04-T Note: The only official Statement of Credit is the one you pull from CPE Monitor. Amedco LLC certifies that the attendee named above has participated in the enduring activity titled IC-ONC: Enduring Whiteboard online between 4/13/2020 and 4/13/2021 and is awarded the number of credit hours listed above.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosures of Conflicts of Interest

Arjun Balar, MD

  • Dr. Balar has received consultant fees from Merck, Genentech, AstraZeneca, Pfizer, and Seattle Genetics; and received fees for non-CME/CE services received directly from a commercial interest or its agent from Merck, Genentech, and AstraZeneca.

CME Content Review

  • The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.

CNE Content Review

  • The content of this activity was peer reviewed by a nurse. The reviewer has nothing to disclose.
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
  • Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
  • Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
  • Nicole Longo, DO, FACOI, Director of Medical and Scientific Services, has nothing to disclose.
  • Ana Maria Albino, Program Manager of Med Learning Group, has nothing to disclose.
  • Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
  • Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Instructions for Participation and Credit

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate for download immediately, you will also get an email reminder.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

ENDURING MATERIAL LEARNER NOTIFICATION

IC-ONC: Enduring Whiteboard
Date of CE Release: April 13, 2020
Date of CE Expiration: April 13, 2021
Location: Online

Acknowledgement of Financial Commercial Support

Bristol-Myers Squibb, Merck & Co., Inc.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles and complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.

If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Successful completion of this program qualifies for up to 1.0 knowledge-based credit hour.

Event UAN(s): JA4008163-9999-20-048-H04-P, JA4008163-9999-20-048-H04-T Note: The only official Statement of Credit is the one you pull from CPE Monitor. Amedco LLC certifies that the attendee named above has participated in the enduring activity titled IC-ONC: Enduring Whiteboard online between 4/13/2020 and 4/13/2021 and is awarded the number of credit hours listed above.
NOTE: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Objectives - After attending this program you should be able to:

  1. Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents.
  2. Review potential predictive or prognostic immune-related biomarkers and biomarker testing methodologies.
  3. Recognize and manage immune-related adverse events (irAEs) associated with the use of checkpoint inhibitors.
  4. Explain patient-centered shared decision-making approaches aimed at optimizing cancer care and survivorship and the roles of the multidisciplinary team members in diagnosing and managing irAEs.

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited

All individuals in a position to control the content of CE are listed below.

Name Commercial Interest
Ana Maria Albino NA
Dr. Balar Consultant: Merck, Genentech, AstraZeneca, Pfizer, and Seattle Genetics; Fees from Non-CME Services: Merck, Genentech, and AstraZeneca
Matthew Frese NA
Christina Gallo NA
Brianna Hanson NA
Nicole Longo NA
Scott McGee-Plys NA